Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PanChol in healthy adults
NCT07107516Phase 1Recruiting
- Sponsor
- Center for Infectious Disease Research in Zambia
- Start
- May 2026
- Primary completion
- Nov 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1 trial of PanChol in cholera (3 cohorts), sponsored by Center for Infectious Disease Research in Zambia. Primary endpoint: Vaccine safety at 14 days. Started May 2026; status: recruiting.
02
Drugs
PanChol
03
Conditions
cholera
Beyond the preview
Go deeper on NCT07107516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07107516.